Acrylamide Functional Group Incorporation Improves Drug-like Properties: An Example with EGFR Inhibitors
Author:
Affiliation:
1. School of Pharmacy and Center for Innovative Therapeutics Discovery, National Taiwan University, Taipei 10055, Taiwan
2. Department of Applied Chemistry, Providence University, Taichung 43301, Taiwan
Funder
Ministry of Education
Publisher
American Chemical Society (ACS)
Subject
Organic Chemistry,Drug Discovery,Biochemistry
Link
https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.8b00270
Reference24 articles.
1. The resurgence of covalent drugs
2. Gaining Insight into Off-Target Mediated Effects of Drug Candidates with a Comprehensive Systems Chemical Biology Analysis
3. Covalent Modifiers: An Orthogonal Approach to Drug Design
4. Irreversible Protein Kinase Inhibitors: Balancing the Benefits and Risks
5. The Role of Extrahepatic Metabolism in the Pharmacokinetics of the Targeted Covalent Inhibitors Afatinib, Ibrutinib, and Neratinib
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Design, synthesis, antiviral evaluation, and In silico studies of acrylamides targeting nsP2 from Chikungunya virus;European Journal of Medicinal Chemistry;2023-10
2. Design and synthesis of gefitinib derivatives as potential drugs for cancer treatment: antiproliferative activity, molecular docking, and ADMET prediction;Letters in Drug Design & Discovery;2023-08-10
3. Polarizable MD and QM/MM investigation of acrylamide-based leads to target the main protease of SARS-CoV-2;The Journal of Chemical Physics;2022-11-14
4. Development of catalyst-free carbon-sulfur bond formation reactions under aqueous media and their applications;Green Synthesis and Catalysis;2022-11
5. Acrylamide fragment inhibitors that induce unprecedented conformational distortions in enterovirus 71 3C and SARS-CoV-2 main protease;Acta Pharmaceutica Sinica B;2022-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3